1. Academic Validation
  2. Isoflavones with unusually modified B-rings and their evaluation as antiproliferative agents

Isoflavones with unusually modified B-rings and their evaluation as antiproliferative agents

  • Bioorg Med Chem Lett. 2009 Nov 15;19(22):6473-6. doi: 10.1016/j.bmcl.2009.08.084.
B Le S Tchize Ndejouong 1 I Sattler H-M Dahse E Kothe C Hertweck
Affiliations

Affiliation

  • 1 Leibniz Institute for Natural Product Research and Infection Biology, HKI, Beutenbergstr. 11a, 07745 Jena, Germany.
Abstract

Six novel isoflavone derivatives along with four known Isoflavones were isolated from a culture of a highly nickel-resistant strain of Streptomyces mirabilis from a former uranium mining area. The structures of 7-hydroxy-3',5'-dihydroxyisoflavone (5), 5,7-dihydroxy-3',5'-dihydroxyisoflavone (6), 2'-hydroxy-3'-methoxygenistein (7), as well as hydroisoflavones A-C (8-10) were elucidated by MS and NMR analyses. Compounds 8-10 feature yet unprecedented types of non-aromatic, hydroxylated B rings, which result from plant isoflavone biotransformation. All new compounds display weak cytotoxic but potent antiproliferative activities. The anti-oestrogenic properties of 8 against MCF-7 human breast Cancer cell line (GI(50): 6 microM) is even higher than the reference compound genistein.

Figures